Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

被引：0

作者：

Michael Borte

Isaac R. Melamed

Grazyna Pulka

Barbara Pyringer

Alan P. Knutsen

Hans D. Ochs

Roger H. Kobayashi

Ai Lan Kobayashi

Sudhir Gupta

Magdalena Strach

William Smits

Anna Pituch-Noworolska

James N. Moy

机构：

[1] Klinikum St. Georg gGmbH,Klinik für Kinder

[2] Hospital St. Georg gGmbH Leipzig, und Jugendmedizin

[3] IMMUNOe Research Center Centennial,Immunodeficiency Centre Leipzig (IDCL)

[4] Uniwersytetu Jagiellońskiego,Klinika Alergologii Collegium Medicum

[5] Octapharma Pharmazeutika Produktionsges.m.b.H,Clinical Research and Development Department

[6] Saint Louis University,Department of Pediatrics

[7] University of Washington and Seattle Children’s Research Institute,Division of Pediatric Allergy/Immunology

[8] UCLA School of Medicine,undefined

[9] University of California,undefined

[10] Jagiellonian University Medical College,undefined

[11] The Allergy and Asthma Center,undefined

[12] University Children Hospital,undefined

[13] Stroger Hospital of Cook County,undefined

来源：

Journal of Clinical Immunology | 2017年 / 37卷

关键词：

Primary immunodeficiency diseases; intravenous immunoglobulin; panzyga®; serious bacterial infections;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：603 / 612

页数：9

共 50 条

[21] Multicenter, open-label, safety and efficacy study of zonisamide in patients with progressive myoclonic epilepsy
Vossler, DG
NEUROLOGY, 2002, 58 (07) : A296 - A297
[22] Efficacy and safety of inhaled low dose iloprost for the treatment of pulmonary hypertension in the early stage: a prospective, multicenter, and open-label study
Sun, Yun-Juan
Xiong, Chang-Ming
Gu, Qing
Zeng, Wei-Jie
He, Jian-Guo
CARDIOLOGY, 2011, 120 : 87 - 87
[23] Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
Tirppur C. R. Ramakrishnan
Somasundaram Kumaravelu
Sunil K. Narayan
Sai S. Buddha
Ch. Murali
Palakkapparampil H. A. Majeed
Salvadeeswaran Meenakshi-Sundaram
Rustom S. Wadia
Vikram Sharma
Indraneel Basu
Pamidimukkala Vijaya
Kizhakkaniyakath A. Salam
Shahid Barmare
Zubin Vaid
K. K. Nirmal Raj
Pandurang R. Wattamwar
Konbappan Asokan
Vijaykumar Dhonge
Shankara Nellikunja
Deepak Namjoshi
Rangasetty Srinivasa
Deepak S. Laddhad
Shirish D. Deshpande
Balakrishnan Raghunath
Jayantee Kalita
Mritunjai Kumar
Usha K. Misra
Methil Pradeep
American Journal of Cardiovascular Drugs, 2018, 18 : 387 - 395
[24] Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials
Ramakrishnan, Tirppur C. R.
Kumaravelu, Somasundaram
Narayan, Sunil K.
Buddha, Sai S.
Murali, Ch
Majeed, Palakkapparampil H. A.
Meenakshi-Sundaram, Salvadeeswaran
Wadia, Rustom S.
Sharma, Vikram
Basu, Indraneel
Vijaya, Pamidimukkala
Salam, Kizhakkaniyakath A.
Barmare, Shahid
Vaid, Zubin
Raj, K. K. Nirmal
Wattamwar, Pandurang R.
Asokan, Konbappan
Dhonge, Vijaykumar
Nellikunja, Shankara
Namjoshi, Deepak
Srinivasa, Rangasetty
Laddhad, Deepak S.
Deshpande, Shirish D.
Raghunath, Balakrishnan
Kalita, Jayantee
Kumar, Mritunjai
Misra, Usha K.
Pradeep, Methil
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (05) : 387 - 395
[25] Safety and Efficacy of Tixagevimab/Cilgavimab (Evusheld) in Autoimmune Inflammatory Rheumatic Disease Patients - a Prospective Multicenter Open-label Study
Eviatar, Tali
Furer, Victoria
Kaufman, Ilana
Levartovsky, David
Elalouf, Ofir
Zisman, Devy
Gazitt, Tal
Haddad, Amir
Elias, Muna
Feld, Joy
Balbir-Gurman, Alexandra
Moscovici, Yolanda Braun
Pel, Sara
Nevo, Sharon
Paran, Daphna
Elkayam, Ori
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 420 - 422
[26] A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis
Glaser, Dee Anna
Pariser, David M.
Hebert, Adelaide A.
Landells, Ian
Somogyi, Chris
Weng, Emily
Brin, Mitchell F.
Beddingfield, Frederick
PEDIATRIC DERMATOLOGY, 2015, 32 (05) : 609 - 617
[27] A Multicenter, Multicohort, Open-Label, Single-Arm per Cohort, Phase II Study to Assess the Efficacy and Safety of Tabelecleucel in Patients with EBV-Associated Diseases Using an Adaptive Two-Stage Study Design
Prockop, S.
Dinavahi, R.
Navarro, W.
Guzman-Becerra, N.
Sun, Y.
Gamelin, L.
BLOOD, 2020, 136
[28] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
Vuppalanchi, Raj
Gonzalez-Huezo, Ma Sarai
Payan-Olivas, Ramon
Munoz-Espinosa, Linda E.
Shaikh, Farheen
Cruz-Lopez, Jose L. Pio
Parmar, Deven
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327
[29] Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: An open-label, multicenter study
Angehrn, F
INTERNATIONAL CONGRESS OF PHLEBOLOGY, 1996, : 93 - 97
[30] EFFICACY AND SAFETY OF CALCIUM DOBESILATE IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY - AN OPEN-LABEL, MULTICENTER STUDY
ANGEHRN, F
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (04): : 346 - 357

← 1 2 3 4 5 →